The FARAPULSE system is now the main revenue driver for the Electrophysiology unit, indicating a massive commercialization and manufacturing scale-up effort. This rapid growth creates pressure on the supply chain, sales training, and marketing operations to support high demand in the US and Japan.
Filing excerpt
We received FDA approval in the United States, and Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan, in the second and third quarters of 2025, respectively, to expand instructions for use labeling to include the treatment of drug refractory, symptomatic persistent AF with the FARAPULSE™ PFA System.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-10kproductLaunchGet every 10-K signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/167dfed1-1800-4dfb-b29d-05f0526687a1 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "167dfed1-1800-4dfb-b29d-05f0526687a1",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-02-24T09:19:12.736+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "The FARAPULSE system is now the main revenue driver for the Electrophysiology unit, indicating a massive commercialization and manufacturing scale-up effort. This rapid growth creates pressure on the supply chain, sales training, and marketing operations to support high demand in the US and Japan.",
"metrics": {
"timeframe": "current_year"
},
"summary": "FARAPULSE PFA System sees rapid adoption after FDA and Japan PMDA approvals in 2025.",
"excerpts": "We received FDA approval in the United States, and Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan, in the second and third quarters of 2025, respectively, to expand instructions for use labeling to include the treatment of drug refractory, symptomatic persistent AF with the FARAPULSE™ PFA System.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000010/bsx-20251231.htm",
"filing_date": "2026-02-17",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"United States",
"Japan"
],
"technologies_mentioned": [
"Pulsed Field Ablation (PFA)"
]
}
}
curl https://signals.autobound.ai/v1/signals/167dfed1-1800-4dfb-b29d-05f0526687a1 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.